Concepedia

Panayiotis Panayiotidis

PP

Statistics

Publications

100

Citations

6.4K

H-Index

37

Active since

1991

Affiliations

National and Kapodistrian University of Athens(Current)

Laiko General Hospital of Athens

University General Hospital Attikon

Athens Medical Center

University College London

Panayiotis Panayiotidis is an author at National and Kapodistrian University of Athens specializing in medicine, oncology, and hematology.

ORCID

Publications per year

1991–2025

100

Publications

100

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial

Andrew H. Wei, Pau Montesinos, Vladimir Ivanov et al. · Blood · 2020 · 756 citations · Full text

, , +9

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber et al. · The Lancet Oncology · 2018 · 611 citations · Full text

, , +11

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

Martin Dreyling, Armando Santoro, Luigina Mollica et al. · Journal of Clinical Oncology · 2017 · 398 citations

, , +13

Interleukin‐2 receptor common γ‐chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti‐apoptotic (<i>bcl‐2, bcl‐x<sub>L</sub></i>) but not pro‐apoptotic (<i>bax, bcl‐x<sub>S</sub></i>) gene expression

Arne N. Akbar, Nicola Borthwick, R. Gitendra Wickremasinghe et al. · European Journal of Immunology · 1996 · 357 citations

, , +17

Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells <i>in vitro</i>

Panayiotis Panayiotidis, Dylan T. Jones, K. Ganeshaguru et al. · British Journal of Haematology · 1996 · 300 citations

, , +10

1–5 of 100